Neuroprotective action at the early stage of Alzheimer’s disease, Parkinson’s disease and polyphenols.

14 March 2024 WHO Globally, more than 1 in 3 people have disease or disability due to neurodegenerative diseases A major new study published by The Lancet Neurology in 2021 showed that more than 3 billion people worldwide were living with a neurodegenerative disease. Neurodegenerative diseases cause great suffering to individuals and their families, affect and deprive human capital from society, burden health systems and economies of countries. Polyphenols target mitochondria and mitigate oxidative stress. This therapeutic potential has attracted considerable attention in recent years.